| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $478K | — | -66.6% |
| Cost of Revenue | $311K | — | -65.6% |
| Gross Profit | $167K | — | -68.3% |
| R&D Expense | $97K | — | +0.0% |
| SG&A Expense | $2.8M | — | -32.3% |
| Operating Income | -$2.6M | — | +28.9% |
| Pre-tax Income | -$4.0M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $31K | -65.6% | -64.8% |
| Accounts Receivable | $1.5M | +0.5% | -92.4% |
| Inventory | $70K | +0.0% | -93.9% |
| Current Assets | $3.1M | -1.2% | -87.4% |
| Total Assets | $58.7M | -1.9% | +17.2% |
| Current Liabilities |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$748K | — | +77.9% |
| Investing Cash Flow | $12K | — | -98.6% |
| Financing Cash Flow | $677K | — | -65.1% |
| +14.9% |
| Income Tax | $1.4M | — | — |
| Net Income | -$5.4M | — | -235.0% |
| EPS (Basic) | -$0.43 | — | -490.9% |
| EPS (Diluted) | -$0.43 | — | -490.9% |
| $56.1M |
| +5.7% |
| +133.3% |
| Total Liabilities | $59.3M | +5.3% | +69.6% |
| Stockholders' Equity | -$614K | -117.5% | -104.1% |